Thanks for visiting Research Information.

You're trying to access an editorial feature that is only available to logged in, registered users of Research Information. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

Thomson Reuters Cortellis

Share this on social media:

Thomson Reuters has launched Thomson Reuters Cortellis, which it describes as the next-generation solution for the life sciences industry. This resource brings together the company’s drug research and development data and the information management technology, ‘to transform the way pharma and biotech professionals access and use data across the entire drug research and development life cycle,’ says the company.

The technology will enable companies to access data hosted within Cortellis and merge it with their own data, or with public data sources. The technology will allow customers access to Thomson Reuters data through an API (application programming interface), and a software development toolkit. This will enable customers to build tailored applications that meet the specific needs of their end-users.

Company: